dc.contributor.author | Jiang, Haoran | |
dc.contributor.author | Kittipibul, Veraprapas | |
dc.contributor.author | Mahfoud, Felix | |
dc.contributor.author | Böhm, Michael | |
dc.contributor.author | Sobotka, Paul A. | |
dc.contributor.author | Esler, Murray | |
dc.contributor.author | Wang, Jie | |
dc.contributor.author | Fudim, Marat | |
dc.date.accessioned | 2025-06-24T15:55:00Z | |
dc.date.available | 2025-06-24T15:55:00Z | |
dc.date.issued | 2024-11-07 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/159671 | |
dc.description.abstract | Activation of the sympathetic nervous system has been attributed to the development of hypertension. Two established approaches for treating hypertension are pharmacotherapy and lifestyle changes. With an improved understanding of renal nerve anatomy and physiology, renal denervation has been proposed as an alternative treatment for hypertension. Specifically, it has been shown that the interruption of sympathetic nerves connecting the kidney and the sympathetic nervous system can reduce blood pressure. Here, we present a review on how renal denervation can help hypertension patients, specifically focusing on our novel understanding of renal nerve anatomy, denervation technique, and subsequent clinical trials, and how it may be used to treat other cardiovascular diseases like heart failure. | en_US |
dc.publisher | Springer US | en_US |
dc.relation.isversionof | https://doi.org/10.1007/s10741-024-10463-1 | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | Springer US | en_US |
dc.title | The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Jiang, H., Kittipibul, V., Mahfoud, F. et al. The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined. Heart Fail Rev 30, 293–314 (2025). | en_US |
dc.contributor.department | Institute for Medical Engineering and Science | en_US |
dc.relation.journal | Heart Failure Reviews | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2025-03-27T13:48:31Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature | |
dspace.embargo.terms | Y | |
dspace.date.submission | 2025-03-27T13:48:30Z | |
mit.journal.volume | 30 | en_US |
mit.license | PUBLISHER_POLICY | |
mit.metadata.status | Authority Work and Publication Information Needed | en_US |